More on AKBA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.19 |
|
|||
| Open | $1.23 | ||||
| 52 Wk High | $13.20 | ||||
| 52 Wk Low | $7.00 | ||||
| Day High | $1.28 | ||||
| Day Low | $1.21 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,460,981 | ||||
- Form 4 Akebia Therapeutics, For: Mar 04 Filed by: Butler John P.
- Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Form 10-K Akebia Therapeutics, For: Dec 31
- Akebia Therapeutics (AKBA) Misses Q4 EPS by 5c
- Form 8-K Akebia Therapeutics, For: Feb 26
- Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights
- Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights
- Form SCHEDULE 13G Akebia Therapeutics, Filed by: STATE STREET CORP
- Akebia Therapeutics (AKBA) PT Lowered to $4 at Piper Sandler
Entities mentioned with AKBA
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Needham & Company | View Related Stories »
- Morgan Stanley | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
